Answers are grounded in this paper and cite their sources.
Introduction Megalencephaly-polymicrogyria-polydactyly-hydrocephalus (MPPH) syndrome is a rare neurodevelopmental disorder associated with activating variants in genes involved in brain growth regulation, including the recurrent PIK3R2 c.1117G > A (p.Gly373Arg) variant. Prenatal diagnosis is challenging because the phenotype may be incompletely characterized on fetal imaging. Case presentation We report a fetus with prenatally detected macrocephaly and ventriculomegaly in a pregnancy conceived through in vitro fertilization in a 27-year-old primigravida. Ultrasound at 24 weeks and 6 days of gestation showed macrocephaly (head circumference, +3.97 standard deviations (SD)). Follow-up ultrasound and fetal magnetic resonance imaging (MRI) at 28 weeks and 2 days confirmed persistent macrocephaly and bilateral ventriculomegaly. No polydactyly or definite polymicrogyria was identified on the available prenatal imaging. Trio whole-exome sequencing (WES) identified a heterozygous PIK3R2 c.1117G > A (p.Gly373Arg) variant that was absent from parental samples and classified as pathogenic using the American College of Medical Genetics and Genomics and Association for Molecular Pathology (ACMG/AMP) framework and Clinical Genome Resource (ClinGen) gene-specific specifications. Following genetic counseling about potential neurodevelopmental outcomes and prognostic uncertainty, the parents elected termination of pregnancy. Discussion MPPH syndrome should be considered in fetuses with unexplained macrocephaly and ventriculomegaly, even when polydactyly or definite cortical malformations are not identified on prenatal imaging. Trio whole-exome sequencing can establish a molecular diagnosis following non-diagnostic chromosomal testing. The recurrent PIK3R2 p.Gly373Arg variant has been associated with a gain-of-function mechanism involving aberrant phosphatidylinositol 3-kinase (PI3 K)–AKT (protein kinase B)–mechanistic target of rapamycin (mTOR) signaling. Conclusion Prenatal WES can establish a molecular diagnosis in selected fetuses with unexplained megalencephaly and ventriculomegaly after non-diagnostic chromosomal testing. Integrating molecular and imaging findings supports genetic counseling and individualized pregnancy management; prenatal imaging may incompletely characterize the phenotype.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: